Bristol Myers Squibb regains exclusive development and commercialization rights for RayzeBio pipeline products in the Greater China market
王俊杰2017
发表于 2024-12-20 11:32:42
135
0
0
On December 19th, Bristol Myers Squibb announced that the company has reached an agreement with AbbVie Pharmaceuticals to regain exclusive rights to develop and commercialize ABZ-706 (equivalent to RYZ801) in the Greater China market for RayzeBio pipeline products. This pipeline product is used for liver cancer treatment targeting GPC3 targets, and a broad licensing agreement previously signed with AbbVie has been terminated, granting AbbVie the right to develop and commercialize up to four RayzeBio pipeline products (including ABZ-706) in these markets.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Apple's fourth quarter revenue slightly exceeded expectations, but revenue in Greater China fell short of expectations
- Apple's latest announcement! Except for Greater China, they are all growing
- Xu Min, Chairman of Procter&Gamble Greater China: Full of long-term confidence and strategic determination in the Chinese market
- Interview with Mao Yibing, President of Marriott International Greater China: Challenges and Opportunities Parallel in the Chinese Market for 50 Years
- Canada Goose welcomes the peak season; Continued growth in Greater China region
- Canada Goose welcomes peak season and continues to grow in Greater China
- Canadian geese withstand the 'cold wind', sales in Greater China increased by 5.7% in the last quarter
- Interview with Qiu You, Chief Operating Officer of InterContinental Hotels Group Greater China: Deeply cultivating local dual track parallel development
- The revenue growth rate of Greater China region exceeds 50%. Amalfin Sports turned losses in the first three quarters and searched for the next "ancestor bird"
- Revenue in Greater China increased by 56%. Amalfin Sports is fully committed to seizing the growth opportunities of Archaeopteryx and Salomon footwear products
